Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study

Clinical Otolaryngology

Volumn 32, Issue 5, 2007, Pages 384-390

  Wiggenraad, R G J ^a,b   Flierman, L ^b   Goossens, A ^b   Brand, R ^c   Verschuur, H P ^b   Croll, G A ^b   Moser, L E C ^b   Vriesendorp, R ^b  

^a Medical Center the Hague   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COLON PERFORATION; COLON SURGERY; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HEAD AND NECK CANCER; HUMAN; MALE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PROPHYLAXIS; TUBE FEEDING; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; DEGLUTITION DISORDERS; ENDOSCOPY, GASTROINTESTINAL; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; GASTROSTOMY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 34648844227     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2007.01533.x     Document Type: Article

References (22)

1. Adelstein D.J., Saxton J.P., Lavertu P. et al. (1997) A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 19, 567 575
2. Brizel D.M., Albers M.E., Fisher S.R. et al. (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 338, 1798 1804
3. Calais G., Alfonsi M., Bardet E. et al. (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J. Natl. Cancer. Inst. 91, 2081 2086
4. Calais G., Bardet E., Sire C. et al. (2004) Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC phaseII trial. Int. J. Radiat. Oncol. Biol. Phys. 58, 161 166
5. Kies M.S., Haraf D.J., Athanasiadis I. et al. (1998) Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J. Clin. Oncol. 16, 2715 2721
6. Langenberg M., Terhaard C.H., Hordijk G.J. et al. (2004) Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital. Clin. Otolaryngol. Allied Sci. 29, 729 734
7. Lin A., Jabbari S., Worden F.P. et al. (2005) Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 63, 1413 1418
8. AlOthman M.O., Amdur R.J., Morris C.G. et al. (2003) Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer? Head Neck 25, 741 747
9. Mekhail T.M., Adelstein D.J., Rybicki L.A. et al. (2001) Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 91, 1785 1790
10. Eisbruch A., Lyden T., Bradford C.R. et al. (2002) Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53, 23 28
11. Mittal B.B., Pauloski B.R., Haraf D.J. et al. (2003) Swallowing dysfunction-preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int. J. Radiat. Oncol. Biol. Phys. 57, 1219 1230
12. Pauloski B.R., Rademaker A.W., Logemann J.A. et al. (2000) Pretreatment swallowing function in patients with head and neck cancer. Head Neck 22, 474 482
13. Lee J.H., Machtay M., Unger L.D. et al. (1998) Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch. Otolaryngol. Head Neck Surg. 124, 871 875
14. Nguyen N.P., North D., Smith H.J. et al. (2006) Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg. Oncol., 15, 199 203.
15. Adelson R.T. Ducic Y. (2005) Metastatic head and neck carcinoma to a percutaneous endoscopic gastrostomy site. Head Neck 27, 339 343
16. Sharma V.K. Howden C.W. (2000) Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am. J. Gastroenterol. 95, 3133 3136
17. Abuksis G., Mor M., Segal N. et al. (2000) Percutaneous endoscopic gastrostomy: high mortality rates in hospitalized patients. Am. J. Gastroenterol. 95, 128 132
18. Adelstein D.J., Saxton J.P., Lavertu P. et al. (2002) Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J. Clin. Oncol. 20, 1405 1410
19. Adelstein D.J., Li Y., Adams G.L. et al. (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J. Clin. Oncol. 21, 92 98
20. Denis F., Garaud P., Bardet E. et al. (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J. Clin. Oncol. 22, 69 76
21. Huguenin P., Beer K.T., Allal A. et al. (2004) Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J. Clin. Oncol. 22, 4665 4673
22. Wendt T.G., Grabenbauer G.G., Rodel C.M. et al. (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J. Clin. Oncol. 16, 1318 1324